Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Research Network

Collaboration Network

27 collaborators·66 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Wisconsin, Madison

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Aminah Jatoi, MD

Mayo Clinic

Moderately Similar
29 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

National Cancer Institute (NCI)NCIC Clinical Trials Group
Similarity Score30%

Edward G. Shaw, MD

Wake Forest University Health Sciences

Moderately Similar
12 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)+4 more
Similarity Score30%

Jeffrey A. Bogart, MD

State University of New York - Upstate Medical University

Related
2 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Alex A. Adjei, MD, PhD

Roswell Park Cancer Institute

Related
5 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Hak Choy, MD

Simmons Cancer Center

Related
5 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Mark Dobelbower, MD PhD

University of Alabama Medical Center

Related
1 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Gregory A. Masters, MD

CCOP - Christiana Care Health Services

Related
1 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Steven E. Schild, MD

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Jeff Sloan, PhD, HSR

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Ken Forster, PhD

H. Lee Moffitt Cancer Center

Related
1 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00062439Phase 2StudyChair

S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors

Lung Cancer
Completed
NCT00533949Phase 3StudyChair

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Lung CancerRadiation Toxicity
Completed

All 2 trials loaded